Medical Transcription Billing, Corp. (MTBC) and Tabula Rasa HealthCare (TRHC) Head-To-Head Contrast

Medical Transcription Billing, Corp. (NASDAQ: MTBC) and Tabula Rasa HealthCare (NASDAQ:TRHC) are both small-cap computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings.

Profitability

This table compares Medical Transcription Billing, Corp. and Tabula Rasa HealthCare’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Medical Transcription Billing, Corp. -32.88% -59.52% -19.17%
Tabula Rasa HealthCare -4.94% -10.59% -8.00%

Insider & Institutional Ownership

7.3% of Medical Transcription Billing, Corp. shares are owned by institutional investors. Comparatively, 28.9% of Tabula Rasa HealthCare shares are owned by institutional investors. 53.5% of Medical Transcription Billing, Corp. shares are owned by company insiders. Comparatively, 45.8% of Tabula Rasa HealthCare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Medical Transcription Billing, Corp. and Tabula Rasa HealthCare’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Medical Transcription Billing, Corp. $30.18 million 0.58 -$2.56 million ($1.08) -1.42
Tabula Rasa HealthCare $108.83 million 3.99 $2.26 million ($0.74) -33.96

Tabula Rasa HealthCare has higher revenue and earnings than Medical Transcription Billing, Corp.. Tabula Rasa HealthCare is trading at a lower price-to-earnings ratio than Medical Transcription Billing, Corp., indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current ratings and target prices for Medical Transcription Billing, Corp. and Tabula Rasa HealthCare, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medical Transcription Billing, Corp. 0 0 1 0 3.00
Tabula Rasa HealthCare 0 1 4 0 2.80

Medical Transcription Billing, Corp. presently has a consensus target price of $2.25, suggesting a potential upside of 47.06%. Tabula Rasa HealthCare has a consensus target price of $19.20, suggesting a potential downside of 23.60%. Given Medical Transcription Billing, Corp.’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Medical Transcription Billing, Corp. is more favorable than Tabula Rasa HealthCare.

Summary

Tabula Rasa HealthCare beats Medical Transcription Billing, Corp. on 9 of the 12 factors compared between the two stocks.

Medical Transcription Billing, Corp. Company Profile

Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform. PracticePro includes practice management software and related tools, which facilitate the day-to-day operation of a medical practice; electronic health records (EHR), which allow its customers to qualify for government incentives; revenue cycle management (RCM) services, which include medical billing, analytics and related services, and mobile Health (mHealth) solutions, including smartphone applications that assist patients and healthcare providers in the provision of healthcare services. The Company offers a clearinghouse service, which allows clients to track claim status.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc. (Tabula Rasa), formerly CareKinesis, Inc., is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs. It also provides risk adjustment services, which help its clients to properly characterize a patient’s acuity, or severity of health condition, and optimize the associated payments for care. The Company serves approximately 100 healthcare organizations that focus on populations with complex healthcare needs and extensive medication requirements. Its products and services are built around the Medication Risk Mitigation Matrix, or MRM Matrix.

Receive News & Ratings for Medical Transcription Billing Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing Corp. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply